A list of words that are forbidden for use in life and annuity advertisements.
One third say they will now cut back on Medicaid and insurance programs they currently accept
WASHINGTON--(BUSINESS WIRE)-- In an MDLinx (www.mdlinx.com) survey of U.S. primary care physicians taken today following the Supreme Court’s upholding of the Affordable Care Act (ACA) ruling, 64 percent said that they did not believe the law could achieve its objective of 100 percent healthcare coverage for Americans. MDLinx, a web property of M3 USA (http://usa.m3.com) is the nation’s leading specialty physician portal. The poll, conducted in the hours following the ruling, surveyed 243 double-verified U.S. primary care physicians.
“The survey showed a surprisingly high level of skepticism among primary care physicians,” said Stephen Smith, Chief Marketing Officer for MDLinx. “Only 22 percent felt that the larger patient population backers promised would have an extremely positive impact on their medical practice, while 45.7 percent felt they would suffer an extremely negative impact.” Some survey participants expressed support for the ACA concept, but feared the resources were simply not available. “It is the ethical thing to do to provide care to the poor,” said one physician. “But I am scared that there will not be sufficient numbers of primary care providers to meet the increased demand.”
Many survey respondents on Thursday expressed doubt that the private insurance market would be an option for many. “People will always choose food for families before insurance. You can't make some people sign up,” said one doctor who responded to the survey. Others doubted that the true costs of the law had been considered. “We can’t print money in large enough quantities,” said one doctor. “It will bankrupt the country,” said another. Yesterday, MDLinx released a poll of physician owners and partners in small practices that showed 26.4 percent that said they could foresee closing their practices within the next year given the current financial environment (see MDLinx Survey Results).
About M3 USA
M3 USA is a part of M3, Inc. and M3 Group. M3 Group operates in the US, Asia, and Europe with more than 1 million physician members globally via its physician websites such as www.m3.com, www.mdlinx.com, www.doctors.net.uk, and www.medigate.net.
M3, Inc., a publicly traded company on the Tokyo Stock Exchange (JP: 2413) provides services to healthcare and life science industry to reach out to their audience. M3 services include medical education, ethical drug promotion, market research, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington DC, and Princeton, Oxford, London and Seoul.
MDLinx (www.mdlinx.com) is an award-winning, practical medical information tool used by busy physicians and healthcare professionals to stay up to date with the latest research in the medical field. On a daily basis, the company’s physician editors read, rank and sort published data and research from leading news media and more than 1,300 peer-reviewed journals in 35 specialties. MDLinx’s content and services are provided at no charge to member physicians. MDLinx is a web property of M3 USA, http://usa.m3.com, which offers information solutions to healthcare providers and industry.
Greg Jones, 908-310-3508